A Self‐Priming Pyroptosis‐Inducing Agent for Activating Anticancer Immunity
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202500610 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Yanjie Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China. Hauptthemen laut MEDLINE: Pyroptosis, Manganese Compounds, Oxides, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Zhejiang Province, Central Guidance on Local Science and Technology Development Fund of Zhejiang Province.
Abstract (Originalsprache)
Pyroptosis, a form of programmed cell death mediated by the gasdermin family, has emerged as a promising strategy for inducing anti‐tumor immunity. However, efficiently inducing pyroptosis in tumor cells remains a significant challenge due to the limited activation of key mediators like caspases in tumor tissues. Herein, a self‐priming pyroptosis‐inducing agent (MnNZ@OMV) is developed by integrating outer membrane vesicles (OMVs) with manganese dioxide nanozymes (MnNZ) to trigger pyroptosis in tumor cells. OMVs, derived from Escherichia coli , are coated onto spiny MnNZ to prepare MnNZ@OMV. Once internalized by tumor cells, MnNZ@OMV responds to elevated intracellular glutathione (GSH) levels, releasing Mn 2 ⁺ and OMV components. This leads to GSH depletion and Mn 2 ⁺‐catalyzed reactive oxygen species generation, which triggers NF‐κB translocation and prime caspase‐11 expression. Subsequently, lipopolysaccharides from OMVs activate caspase‐11, resulting in GSDMD cleavage and pyroptosis induction. MnNZ@OMV significantly induces tumor pyroptosis in vivo, promoting dendritic cell maturation and CD8⁺ T cell activation, leading to robust anti‐tumor effects. Collectively, this study presents a novel self‐priming approach for inducing tumor cell pyroptosis through the noncanonical caspase‐11/GSDMD pathway, offering a promising avenue for future cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China.
- Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, 310009, China.
- Research Center of Diagnosis and Treatment Technology for Hepatocellular Carcinoma of Zhejiang Province, Hangzhou, 310009, China.
- Center for Medical Research and Innovation in Digestive System Tumors, Ministry of Education, Hangzhou, 310009, China.
- Cancer Center, Zhejiang University, Hangzhou, 310058, China.
- ZJU-Pujian Research & Development Center of Medical Artificial Intelligence for Hepatobiliary and Pancreatic Disease, Hangzhou, 310058, China.
ORCID-Profile: Yuan Ding, Zhengwei Mao, Yang Du, Weilin Wang
Förderung
- National Natural Science Foundation of China
- Key Research and Development Program of Zhejiang Province
- Central Guidance on Local Science and Technology Development Fund of Zhejiang Province
- Key Project of Traditional Chinese Medicine Science and Technology Plan of Zhejiang Province
- Postdoctoral Fellowship Program of CPSF
Zitieren
APA
Li, Y., Feng, H., Yang, H., Wang, Y., Ding, Y., Mao, Z., Du, Y., & Wang, W. (2025). A Self‐Priming Pyroptosis‐Inducing Agent for Activating Anticancer Immunity. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202500610
Vancouver
Li Y, Feng H, Yang H, Wang Y, Ding Y, Mao Z, et al. A Self‐Priming Pyroptosis‐Inducing Agent for Activating Anticancer Immunity. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202500610
BibTeX
@article{Li2025,
author = {Li, Yanjie and Feng, Hanxin and Yang, Huang and Wang, Yi and Ding, Yuan and Mao, Zhengwei and Du, Yang and Wang, Weilin},
title = {A Self‐Priming Pyroptosis‐Inducing Agent for Activating Anticancer Immunity},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202500610}
}
EUVIMED